U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C6H5O7.In
Molecular Weight 300.0048
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, indium(3+)-111In salt (1:1)

SMILES

[111In+3].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O

InChI

InChIKey=VSEUCCPAJZHJSX-JWFOFJTQSA-K
InChI=1S/C6H8O7.In/c7-3(8)1-6(13,5(11)12)2-4(9)10;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);/q;+3/p-3/i;1-4

HIDE SMILES / InChI
Indium In-111 pentetate disodium is a radioactive diagnostic indicated for use in radionuclide cisternography. Decay of In-111 by electron capture allows for detection with a gamma camera for visualization of the brain and spinal column. Indium In 111 pentetate ( 111In-DTPA) is indicated as an imaging agent in cisternography to study the flow of cerebrospinal fluid (CSF) in the brain, to diagnose abnormalities in CSF circulation, to assess and help localize the site of CSF leakage, and to test the patency of or localize blocks in CSF shunts.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
MPI INDIUM DTPA IN 111

Approved Use

Unknown

Launch Date

1982
Diagnostic
MPI INDIUM DTPA IN 111

Approved Use

Unknown

Launch Date

1982
Diagnostic
MPI INDIUM DTPA IN 111

Approved Use

Unknown

Launch Date

1982

Sample Use Guides

The maximum recommended intrathecal dose in the average patient (70 kg) is 18.5 MBq, 500 μCi. The patient dose should be measured by a suitable radioactivity calibration system immediately prior to administration.
Route of Administration: Other
Name Type Language
1,2,3-Propanetricarboxylic acid, 2-hydroxy-, indium(3+)-111In salt (1:1)
Preferred Name English
INDIUM CITRATE (INDIUM-111)
Common Name English
Code System Code Type Description
FDA UNII
33QB3K8SC6
Created by admin on Wed Apr 02 19:47:16 GMT 2025 , Edited by admin on Wed Apr 02 19:47:16 GMT 2025
PRIMARY
CAS
71895-21-1
Created by admin on Wed Apr 02 19:47:16 GMT 2025 , Edited by admin on Wed Apr 02 19:47:16 GMT 2025
PRIMARY